Key facts
- Treat Systems’s last known valuation is $317.1M (Jan 2025).
- It has raised $61.4M; the latest was Later Stage VC ($56.8M) in Jan 2025.
- Notable investors include Accelerace, Interreg North-West Europe.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Treat Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for Treat Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Treat Systems
Developer of a medical decision support system designed to improve the clinical outcome of patients with infections while preserving the effectiveness of antimicrobials for future human generations. The company's decision support system combines and supports all aspects of antimicrobial therapy in clinical practice, enabling physicians to prescribe appropriate antibiotics for infectious diseases.
- Sector
- Healthcare
- HQ
- Aalborg, Denmark
- Founded
- 2007
- Employees
- 5
- Website
- treatsystems.com/
- Ownership
- Privately Held (backing)
Treat Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Treat Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Treat Systems in its N-PORT filings yet. We sweep new filings monthly.